{"abstract": "A legal brief says Johnson & Johnson has been asked whether Alere\u2019s recalled INRatio blood-testing monitor compromised the anticlotting drug\u2019s trial.", "web_url": "https://www.nytimes.com/2016/02/23/business/fda-asks-if-faulty-blood-monitor-tainted-xarelto-approval.html", "snippet": "A legal brief says Johnson & Johnson has been asked whether Alere\u2019s recalled INRatio blood-testing monitor compromised the anticlotting drug\u2019s trial.", "lead_paragraph": "The Food and Drug Administration is investigating whether a faulty blood-testing device may have compromised the results of a clinical trial that led to the approval of Xarelto, a blockbuster anticlotting drug that has been prescribed to millions of Americans since it arrived on the market in 2011.", "print_section": "B", "print_page": "1", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2016/02/23/business/23DRUG/23DRUG-articleLarge.jpg", "height": 405, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2016/02/23/business/23DRUG/23DRUG-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 405}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2016/02/23/business/23DRUG/23DRUG-jumbo.jpg", "height": 691, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2016/02/23/business/23DRUG/23DRUG-superJumbo.jpg", "height": 1382, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2016/02/23/business/23DRUG/23DRUG-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2016/02/23/business/23DRUG/23DRUG-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2016/02/23/business/23DRUG/23DRUG-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "F.D.A. Asks If Faulty Blood Monitor Tainted Xarelto Approval", "kicker": null, "content_kicker": null, "print_headline": "F.D.A. Seeks New Details in Approval of Xarelto   ", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "persons", "value": "Thomas, Katie", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Johnson & Johnson", "rank": 3, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 4, "major": "N"}, {"name": "subject", "value": "Blood Clots", "rank": 5, "major": "N"}, {"name": "subject", "value": "Clinical Trials", "rank": 6, "major": "N"}, {"name": "subject", "value": "Recalls and Bans of Products", "rank": 7, "major": "N"}, {"name": "organizations", "value": "Bayer AG", "rank": 8, "major": "N"}, {"name": "organizations", "value": "European Medicines Agency", "rank": 9, "major": "N"}, {"name": "organizations", "value": "Alere Inc", "rank": 10, "major": "N"}], "pub_date": "2016-02-22T23:26:55+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Katie Thomas", "person": [{"firstname": "Katie", "middlename": null, "lastname": "Thomas", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/2a366d45-c44d-5e1a-ae0a-cb4a734cc4c7", "word_count": 1420, "uri": "nyt://article/2a366d45-c44d-5e1a-ae0a-cb4a734cc4c7"}